ALEXION PHARMACEUTICALS, INC. 4 SEC Filings

Filed On	Filing
23 Jul 2021	Form 4: Coughlin Christopher J, Director Returned 42,347 shares to the issuer · Disposed of 7,343 Option to Purchase Common Stock (Disposition to Issuer) ($1.14M)
23 Jul 2021	Form 4: Sarin Aradhana, EVP, CFO Returned 120,253 shares to the issuer
23 Jul 2021	Form 4: Friedman Paul A, Director Returned 12,840 shares to the issuer
23 Jul 2021	Form 4: Reinsdorf Judith A, Director Returned 14,150 shares to the issuer
23 Jul 2021	Form 4: Dunsire Deborah, Director Returned 14,629 shares to the issuer
23 Jul 2021	Form 4: Carino Tanisha, EVP & CCAO Returned 59,226 shares to the issuer
23 Jul 2021	Form 4: Mollen John T, Director Returned 15,336 shares to the issuer · Disposed of 7,422 Option to Purchase Common Stock (Disposition to Issuer) ($1.13M)
23 Jul 2021	Form 4: Brennan David R, Director Returned 20,873 shares to the issuer · Disposed of 7,343 Option to Purchase Common Stock (Disposition to Issuer) ($1.14M)
23 Jul 2021	Form 4: Goff Brian, EVP & Chief Commercial Officer Returned 150,832 shares to the issuer · Disposed of 21,750 Option to Purchase Common Stock (Disposition to Issuer) ($2.18M)
23 Jul 2021	Form 4: Chiniara Ellen, EVP & Chief Legal Officer Returned 116,850 shares to the issuer
23 Jul 2021	Form 4: Bazarko Daniel, SVP, Controller, CAO Returned 60,207 shares to the issuer · Disposed of 17,266 Option to Purchase Common Stock (Disposition to Issuer) ($2.84M)
23 Jul 2021	Form 4: Franchini Indrani Lall, EVP, Chief Compliance Officer Returned 116,075 shares to the issuer · Disposed of 25,165 Option to Purchase Common Stock (Disposition to Issuer) ($2.52M)
23 Jul 2021	Form 4: Nader Francois, Director Returned 13,921 shares to the issuer
23 Jul 2021	Form 4: Rummelt Andreas, Director Returned 28,109 shares to the issuer · Disposed of 14,084 Option to Purchase Common Stock (Disposition to Issuer) ($1.73M)
23 Jul 2021	Form 4: Hantson Ludwig, Director Returned 580,809 shares to the issuer · Disposed of 56,762 Option to Purchase Common Stock (Disposition to Issuer) ($6.75M)
23 Jul 2021	Form 4: Orloff John J, EVP, Research & Development Returned 146,511 shares to the issuer
16 Jul 2021	Form 4: Hantson Ludwig, Director Received 240,741 shares as a grant or award
16 Jul 2021	Form 4: Sarin Aradhana, EVP, CFO Received 56,313 shares as a grant or award
16 Jul 2021	Form 4: Franchini Indrani Lall, EVP, Chief Compliance Officer Received 52,625 shares as a grant or award
16 Jul 2021	Form 4: Bazarko Daniel, SVP, Controller, CAO Received 21,708 shares as a grant or award

Comments